论文信息 - A Phase 1/2 Study of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) - 字舞流文

A Phase 1/2 Study of G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (G-CLAM) in Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

E. Estey | M. Othus | R. Walter | H. Erba | P. Becker | P. Hendrie | B. Scott | M. Percival | S. Buckley | A. Halpern | Tara L. Chen | E. Huebner | K. F. Orlowski | Heather A Smith | Andrea M. Perdue | Heather A. Smith